Syft sees at least $350m pa opportunity in life sciences
Christchurch company is diversifying from semiconductors into pharma and chemicals.
Will Mace Thu, 07 Apr 2022
Syft Technologies has already scoped a $350 million per year market opportunity for just one application of its technology in the life sciences space, as it pushes to diversify its revenue stream beyond semiconductor manufacturers.
Christchurch-based Syft, which makes mass spectrometer sensors
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
